Rosiglitazone (Avandia) suspended from the Saudi Arabian market
The Saudi Food and Drug Authority (SFDA) announced on March 14, 2010 that the marketing authorization for rosiglitazone (Avandia) and all combination products containing rosiglitazone was suspended for...